Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...